Zobrazeno 1 - 10
of 382
pro vyhledávání: '"Wolf AI"'
Autor:
Xie F; Bioimaging (F.X., T.G., M.R.G.), Nonclinical Safety (M.A.R.), and Immunology Research (A.I.W.), GlaxoSmithKline, Collegeville, Pennsylvania fang.x.xie@gsk.com., Gales T; Bioimaging (F.X., T.G., M.R.G.), Nonclinical Safety (M.A.R.), and Immunology Research (A.I.W.), GlaxoSmithKline, Collegeville, Pennsylvania., Ringenberg MA; Bioimaging (F.X., T.G., M.R.G.), Nonclinical Safety (M.A.R.), and Immunology Research (A.I.W.), GlaxoSmithKline, Collegeville, Pennsylvania., Wolf AI; Bioimaging (F.X., T.G., M.R.G.), Nonclinical Safety (M.A.R.), and Immunology Research (A.I.W.), GlaxoSmithKline, Collegeville, Pennsylvania., Groseclose MR; Bioimaging (F.X., T.G., M.R.G.), Nonclinical Safety (M.A.R.), and Immunology Research (A.I.W.), GlaxoSmithKline, Collegeville, Pennsylvania.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Oct 16; Vol. 52 (11), pp. 1181-1186. Date of Electronic Publication: 2024 Oct 16.
Autor:
Sircy, Linda M.1 (AUTHOR), Ramstead, Andrew G.1,2 (AUTHOR), Gibbs, Lisa C.1 (AUTHOR), Joshi, Hemant1 (AUTHOR), Baessler, Andrew1 (AUTHOR), Mena, Ignacio3,4 (AUTHOR), García-Sastre, Adolfo3,4,5,6,7 (AUTHOR), Emerson, Lyska L.1,2 (AUTHOR), Fairfax, Keke C.1 (AUTHOR), Williams, Matthew A.1,2 (AUTHOR) matthew.williams@path.utah.edu, Hale, J. Scott1 (AUTHOR) scott.hale@path.utah.edu
Publikováno v:
PLoS Pathogens. 9/16/2024, Vol. 20 Issue 9, p1-32. 32p.
Autor:
Washburn ML; Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426; michael.l.washburn@gsk.com hotch@wustl.edu., Wang Z; Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426.; Institute of Ecological Science, School of Life Science, South China Normal University, Guangzhou 510630, China., Walton AH; Department of Anesthesiology, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110., Goedegebuure SP; Department of Surgery, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.; Siteman Cancer Center, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110; and., Figueroa DJ; Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426., Van Horn S; Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426., Grossman J; Department of Surgery, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110., Remlinger K; Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426., Madsen H; Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426., Brown J; Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426., Srinivasan R; Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426., Wolf AI; Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426., Berger SB; Pharmaceuticals Research and Development, GlaxoSmithKline, Collegeville, PA 19426., Yi VN; Department of Anesthesiology, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110., Hawkins WG; Department of Surgery, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.; Siteman Cancer Center, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110; and., Fields RC; Department of Surgery, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.; Siteman Cancer Center, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110; and., Hotchkiss RS; Department of Anesthesiology, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110; michael.l.washburn@gsk.com hotch@wustl.edu.; Department of Surgery, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.; Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2019 Oct 01; Vol. 203 (7), pp. 1897-1908. Date of Electronic Publication: 2019 Sep 04.
Autor:
Ramanjulu JM; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA. joshi.m.ramanjulu@gsk.com., Pesiridis GS; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Yang J; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Concha N; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Singhaus R; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Zhang SY; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Tran JL; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Moore P; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Lehmann S; Cellzome, GlaxoSmithKline R&D, Heidelberg, Germany., Eberl HC; Cellzome, GlaxoSmithKline R&D, Heidelberg, Germany., Muelbaier M; Cellzome, GlaxoSmithKline R&D, Heidelberg, Germany., Schneck JL; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Clemens J; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Adam M; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Mehlmann J; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Romano J; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Morales A; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Kang J; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Leister L; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Graybill TL; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Charnley AK; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Ye G; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Nevins N; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Behnia K; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Wolf AI; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Kasparcova V; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Nurse K; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Wang L; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Puhl AC; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Li Y; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Klein M; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Hopson CB; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Guss J; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Bantscheff M; Cellzome, GlaxoSmithKline R&D, Heidelberg, Germany., Bergamini G; Cellzome, GlaxoSmithKline R&D, Heidelberg, Germany., Reilly MA; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Lian Y; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Duffy KJ; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Adams J; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Foley KP; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Gough PJ; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Marquis RW; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Smothers J; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Hoos A; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Bertin J; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA.
Publikováno v:
Nature [Nature] 2019 Jun; Vol. 570 (7761), pp. E53.
Autor:
Ramanjulu JM; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA. joshi.m.ramanjulu@gsk.com., Pesiridis GS; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Yang J; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Concha N; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Singhaus R; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Zhang SY; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Tran JL; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Moore P; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Lehmann S; Cellzome, GlaxoSmithKline R&D, Heidelberg, Germany., Eberl HC; Cellzome, GlaxoSmithKline R&D, Heidelberg, Germany., Muelbaier M; Cellzome, GlaxoSmithKline R&D, Heidelberg, Germany., Schneck JL; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Clemens J; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Adam M; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Mehlmann J; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Romano J; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Morales A; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Kang J; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Leister L; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Graybill TL; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Charnley AK; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Ye G; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Nevins N; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Behnia K; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Wolf AI; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Kasparcova V; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Nurse K; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Wang L; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Puhl AC; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Li Y; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Klein M; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Hopson CB; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Guss J; Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA., Bantscheff M; Cellzome, GlaxoSmithKline R&D, Heidelberg, Germany., Bergamini G; Cellzome, GlaxoSmithKline R&D, Heidelberg, Germany., Reilly MA; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Lian Y; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Duffy KJ; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Adams J; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Foley KP; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Gough PJ; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Marquis RW; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Smothers J; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Hoos A; Immuno-Oncology & Combinations DPU, GlaxoSmithKline, Collegeville, PA, USA., Bertin J; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA.
Publikováno v:
Nature [Nature] 2018 Dec; Vol. 564 (7736), pp. 439-443. Date of Electronic Publication: 2018 Nov 07.
Autor:
Glatman Zaretsky A; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Konradt C; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Dépis F; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA., Wing JB; Laboratory of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Suita 565-0871, Japan., Goenka R; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Atria DG; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Silver JS; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Cho S; Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA., Wolf AI; The Wistar Institute, Philadelphia, PA 19104, USA., Quinn WJ; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Engiles JB; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Brown DC; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Beiting D; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Erikson J; The Wistar Institute, Philadelphia, PA 19104, USA., Allman D; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Cancro MP; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Sakaguchi S; Laboratory of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Suita 565-0871, Japan., Lu LF; Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA., Benoist CO; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA., Hunter CA; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: chunter@vet.upenn.edu.
Publikováno v:
Cell reports [Cell Rep] 2017 Feb 21; Vol. 18 (8), pp. 1906-1916.
Autor:
Patel MN; Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK., Carroll RG; Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland., Galván-Peña S; Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland., Mills EL; Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland., Olden R; Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK; Institute of Infection and Immunity, School of Medicine, University Hospital of Wales, Cardiff University, Cardiff, UK., Triantafilou M; Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK; Institute of Infection and Immunity, School of Medicine, University Hospital of Wales, Cardiff University, Cardiff, UK., Wolf AI; Host Defense Discovery Performance Unit, Infectious Diseases Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19426, USA., Bryant CE; Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK; Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB23 8AQ, UK., Triantafilou K; Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK; Institute of Infection and Immunity, School of Medicine, University Hospital of Wales, Cardiff University, Cardiff, UK., Masters SL; Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK; Department of Medical Biology, University of Melbourne, Parkville 3010, Australia; Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia. Electronic address: masters@wehi.edu.au.
Publikováno v:
Trends in molecular medicine [Trends Mol Med] 2017 Feb; Vol. 23 (2), pp. 165-180. Date of Electronic Publication: 2017 Jan 18.
Autor:
Plaut, Edward Webre, Powers, Elizabeth
Publikováno v:
University of Michigan Journal of Law Reform. Spring2024, Vol. 57 Issue 3, p611-659. 49p.